Faculty Profiles - TANABE Shunsuke

MISC - TANABE Shunsuke

Division display 641 - 660 of about 660 ／ All the affair displays >>

当院における大腸癌肝転移に対する治療戦略単発例,多発例を比較検討して

田辺俊介, 稲垣優, 藤井清香, 徳永尚之, 常光洋輔, 大塚眞哉, 三好和也, 大崎俊英, 淵本定儀, 湯村正仁

日本消化器外科学会雑誌 39 ( 7 ) 1273 - 1273 2006.7

進行膵癌に対するGemcitabineを用いた化学療法の効果

稲垣優, 田辺俊介, 徳永尚之, 藤井清香, 常光洋輔, 大塚眞哉, 三好和也, 大崎俊英, 淵本定儀, 湯村正仁

日本消化器外科学会雑誌 39 ( 7 ) 1156 - 1156 2006.7

当院におけるss胆嚢癌手術症例の検討手術術式と予後の関係

徳永尚之, 稲垣優, 田辺俊介, 常光洋輔, 有木則文, 大塚眞哉, 三好和也, 大崎俊英, 淵本定儀, 湯村正仁

日本消化器外科学会雑誌 39 ( 7 ) 1299 - 1299 2006.7

当院における転移性肝癌の切除症例の検討

田辺俊介, 稲垣優, 徳永尚之, 常光洋輔, 有木則文, 大塚眞哉, 三好和也, 高橋正彦, 大崎俊英, 淵本定儀, 湯村正仁

日本外科学会雑誌 107 ( 臨増2 ) 628 - 628 2006.3

非代償期肝硬変による難治性胸水に対する胸腔静脈シャントの経験

稲垣優, 田辺俊介, 吉田亮介, 有木則文, 常光洋輔, 大塚眞哉, 三好和也, 大崎俊英, 淵本定儀, 湯村正仁, 堀圭介, 友田純

肝臓 46 ( 11 ) 653 - 657 2005.11

Language：Japanese Publisher：(一社)日本肝臓学会

67歳女.患者はC型肝硬変症にて経過を追っていた.胸水穿刺を繰り返していたが,難治性のため胸腔ドレーンを挿入した.胸腔ドレーンをクランプすると呼吸困難を生じ,胸部レントゲンにて縦隔の左方への移動を認めた.中等度の肝機能障害を認め,胸腔静脈シャントの必要性があると判断し,手術が施行された.300回/日から1000回/日にポンプを増やしたが改善が認められず,回数の増加と胸水穿刺を適時行った.その結果,以後,呼吸状態も改善し退院となった.術後1年6ヵ月経過現在,外来通院中であるが,100回/月で胸水の貯留は見られていない

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00263&link_issn=&doc_id=20051220460003&doc_link_id=10.2957%2Fkanzo.46.653&url=https%3A%2F%2Fdoi.org%2F10.2957%2Fkanzo.46.653&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

進行大腸癌におけるPyNPase/DPD活性と臨床病理学的検討

大塚眞哉, 田辺俊介, 常光洋輔, 有木則文, 三好和也, 稲垣優, 高橋正彦, 大崎俊英, 淵本定儀, 湯村正仁

癌と化学療法 32 ( 11 ) 1679 - 1681 2005.10

Language：Japanese Publisher：(株)癌と化学療法社

進行大腸癌70例を対象に腫瘍組織,隣接正常組織のpyrimidine nucleoside phosphorylase(PyNPase)およびdihydropyrimidine dehydrogenase(DPD)酵素活性を測定し,臨床病理学的検討と予後について検討した.PyNPaseは腫瘍部で82.7±41.9U/mg protein(正常部は37.2±24.0U/mg protein)と高値を示し(p<0.001)反対にDPDは正常部で40.3±19.4U/mg protein(腫瘍部は33.8±18.0U/mg protein)と高値を示した(p<0.05).病理組織学的検討においてはリンパ節転移陽性症例では,リンパ節転移陰性症例に対してPyNPaseは高値を示した(p<0.05).術後補助療法にてgrade2以上の副作用発現症例では正常組織のDPD活性は有意に低値を示した(p<0.05).治癒切除可能であったDukes'B,C症例について予後を検討するとPyNPase活性高値の症例は低値の症例に対して再発例は多かったが,術後補助化学療法として5'-DFUR投与した群では無再発生存期間の延長を認めた(p<0.05)(著者抄録)

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2005&ichushi_jid=J00296&link_issn=&doc_id=20051107280046&doc_link_id=%2Fab8gtkrc%2F2005%2F003211%2F046%2F1679-1681%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fab8gtkrc%2F2005%2F003211%2F046%2F1679-1681%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

当院における80歳以上の超高齢者における肝胆膵領域の悪性腫瘍手術症例の検討

田辺俊介, 稲垣優, 徳永尚之, 常光洋輔, 黒木慶一郎, 有木則文, 大塚眞哉, 三好和也, 高橋正彦, 大崎俊英, 淵本定儀, 湯村正仁

日本臨床外科学会雑誌 66 ( 増刊 ) 952 - 952 2005.10

治癒切除を施行しえた直腸原発小細胞癌の一例

常光洋輔, 大崎俊英, 田辺俊介, 徳永尚之, 黒木慶一郎, 有木則文, 大塚眞哉, 三好和也, 稲垣優, 高橋正彦, 淵本定儀, 湯村正仁

日本臨床外科学会雑誌 66 ( 増刊 ) 861 - 861 2005.10

[Clinicopathological significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced colorectal cancer]. Reviewed

Shinya Otsuka, Shunsuke Tanabe, Yousuke Tsunemitsu, Norifumi Ariki, Kazuya Miyoshi, Masaru Inagaki, Masahiko Takahashi, Toshihide Oosaki, Sadanori Fuchimoto, Masahito Yumura

Gan to kagaku ryoho. Cancer & chemotherapy 32 ( 11 ) 1679 - 81 2005.10

Language：Japanese

We examined clinicopathological characteristics and prognoses of seventy advanced colorectal cancer cases by measuring pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in tumor and normal tissue. PyNPase activities in cancerous tissue obtained from resected were 82.7 +/- 41.9 U/mg protein, which were significantly higher than 37.2 +/- 24.0 U/mg protein in normal tissue (p < 0.001). On the other hand, DPD activities in cancerous tissue were significantly lower in normal tissue (p < 0.05). In cases with lymphnode metastases, PyNPase activities of cancerous tissue were significantly higher than that of no lymphnode metastases cases (p < 0.05). In cases with grade 2 side-effects or higher by oral adjuvant chemotherapy, DPD activities in normal tissue were significantly lower than that of other cases (p < 0.05). With regard to Dukes' B and C cases that were resected curatively, PyNPase activities of cancerous tissue of higher group's prognosis were worse than that of the lower group. In the group received 5'-DFUR as adjuvant chemotherapy, non-recurrent survival rate of the group exhibiting higher PyNPase activities was better than that of the lower group.

PubMed

researchmap

安全な肝切除を目指して手術手技の工夫 TissueLink Dissecting Sealerを用いた肝切離の工夫

稲垣優, 田辺俊介, 常光洋輔, 有木則文, 大塚眞哉, 三好和也, 高橋正彦, 大崎俊英, 淵本定儀, 湯村正仁

日本消化器外科学会雑誌 38 ( 7 ) 939 - 939 2005.7

Sudden death from metastatic esophageal cancer to the ventricular septum. Reviewed

Masafumi Kataoka, Kaori Shigemitsu, Shunsuke Tanabe, Toshinori Ohara, Takaomi Takahata, Soichiro Nose

The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 53 ( 7 ) 365 - 8 2005.7

Language：English

A 67-year-old man was admitted to our hospital due to esophageal cancer. Cancer existed at the lower esophagus and subtotal esophagectomy and lymphadenectomy was performed. The postoperative course was uneventful. Pathological findings revealed moderately differentiated squamous cell carcinoma that metastasized to the abdominal lymph nodes which include the paraaortic lymph nodes. He complained of anorexia three months after the operation and was found to have multiple liver and mediastinal lymph node metastases. He was admitted for chemotherapy. Before starting chemotherapy, he suddenly died without any sign of hemorrhage or respiratory disorder. Autopsy showed metastatic lesions to the heart and mediastinal lymph nodes, liver, thoracic vertebrae, kidney, adrenal gland and heart. Metastatic nodules in the heart were on the ventricular septum where the conducting system exists. No direct invasion from the pericardium was observed. Blockade of the conducting system of the heart was considered to have caused the severe arrhythmia and sudden cardiac arrest.

PubMed

researchmap

A case of Castleman's desease on mesenterium of jejunum

60 ( 2 ) 249 - 253 2005.2